137 related articles for article (PubMed ID: 37257418)
1. Change of iron content in brain regions after intravenous iron therapy in restless legs syndrome: quantitative susceptibility mapping study.
Kim TJ; Kim MH; Kim JH; Jun JS; Byun JI; Sunwoo JS; Shin JW; Gho SM; Sohn CH; Jung KY
Sleep; 2023 Aug; 46(8):. PubMed ID: 37257418
[TBL] [Abstract][Full Text] [Related]
2. Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.
Bae H; Cho YW; Kim KT; Li X; Earley CJ
Sleep Med; 2023 Sep; 109():128-131. PubMed ID: 37437492
[TBL] [Abstract][Full Text] [Related]
3. Different iron deposition patterns in hemodialysis patients with and without restless legs syndrome: a quantitative susceptibility mapping study.
Wang H; Han X; Jin M; Wang LY; Diao ZL; Guo W; Zhang P; Wang Z; Ding HY; Lv H; Zhang ZY; Zhao PF; Li J; Yang ZH; Liu WH; Wang ZC
Sleep Med; 2020 May; 69():34-40. PubMed ID: 32045852
[TBL] [Abstract][Full Text] [Related]
4. Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla.
Li X; Allen RP; Earley CJ; Liu H; Cruz TE; Edden RAE; Barker PB; van Zijl PCM
Sleep Med; 2016 Jun; 22():75-82. PubMed ID: 27544840
[TBL] [Abstract][Full Text] [Related]
5. Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients.
Lieske B; Becker I; Schulz RJ; Polidori MC; Kassubek J; Roehrig G
Z Gerontol Geriatr; 2016 Oct; 49(7):626-631. PubMed ID: 26597718
[TBL] [Abstract][Full Text] [Related]
6. Iron for the treatment of restless legs syndrome.
Trotti LM; Becker LA
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007834. PubMed ID: 30609006
[TBL] [Abstract][Full Text] [Related]
7. Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome.
Park HR; Choi SJ; Joo EY; Allen RP
Sleep Med; 2020 Nov; 75():81-87. PubMed ID: 32853922
[TBL] [Abstract][Full Text] [Related]
8. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
Hornyak M; Scholz H; Kiemen A; Kassubek J
Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006
[TBL] [Abstract][Full Text] [Related]
9. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
Bae H; Cho YW; Kim KT; Allen RP; Earley CJ
Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment for restless legs symptoms and low serum ferritin in children with autism spectrum disorder.
DelRosso LM; Reuter-Yuill LM; Cho Y; Ferri R; Mogavero MP; Picchietti DL
Sleep Med; 2022 Dec; 100():488-493. PubMed ID: 36265207
[TBL] [Abstract][Full Text] [Related]
11. Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
Allen R; Oertel W; Walters A; Benes H; Schollmayer E; Grieger F; Moran K; Kohnen R
Sleep Med; 2013 Dec; 14(12):1375-80. PubMed ID: 24246378
[TBL] [Abstract][Full Text] [Related]
12. Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging.
Beliveau V; Stefani A; Birkl C; Kremser C; Gizewski ER; Högl B; Scherfler C
Neuroimage Clin; 2022; 34():103024. PubMed ID: 35500370
[TBL] [Abstract][Full Text] [Related]
13. Lower molecular weight intravenous iron dextran for restless legs syndrome.
Cho YW; Allen RP; Earley CJ
Sleep Med; 2013 Mar; 14(3):274-7. PubMed ID: 23333678
[TBL] [Abstract][Full Text] [Related]
14. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
Schneider J; Krafft A; Manconi M; Hübner A; Baumann C; Werth E; Gyr T; Bassetti C
Sleep Med; 2015 Nov; 16(11):1342-1347. PubMed ID: 26498233
[TBL] [Abstract][Full Text] [Related]
15. Iron for restless legs syndrome.
Trotti LM; Bhadriraju S; Becker LA
Cochrane Database Syst Rev; 2012 May; 5(5):CD007834. PubMed ID: 22592724
[TBL] [Abstract][Full Text] [Related]
16. Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).
Ondo WG; Grieger F; Moran K; Kohnen R; Roth T
J Clin Sleep Med; 2016 Jan; 12(1):63-70. PubMed ID: 26446245
[TBL] [Abstract][Full Text] [Related]
17. Does Improvement of Low Serum Ferritin Improve Symptoms of Restless Legs Syndrome in a Cohort of Pediatric Patients?
Rosen GM; Morrissette S; Larson A; Stading P; Barnes TL
J Clin Sleep Med; 2019 Aug; 15(8):1149-1154. PubMed ID: 31482837
[TBL] [Abstract][Full Text] [Related]
18. Combined resting state functional magnetic resonance imaging and diffusion tensor imaging study in patients with idiopathic restless legs syndrome.
Zhuo Y; Wu Y; Xu Y; Lu L; Li T; Wang X; Li K
Sleep Med; 2017 Oct; 38():96-103. PubMed ID: 29031764
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies.
Yang X; Yang B; Ming M; Li S; Wang F; Zhu Z; Ji C; Long J; Hu F; Xu Z; Ren H; Liu B
Sleep Med; 2019 Sep; 61():110-117. PubMed ID: 31395522
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
